https://www.cnbc.com/2023/03/09/alzheimers-eli-lilly-treatment-solanezumab-failed-to-slow-disease.html
0
0
3/9/23 at 4:34am
Organization
CNBC
Author
Spencer Kimball
33 words
0
Comments
Solanezumab's failure is a blow to efforts to treat Alzheimer's in people who have not yet shown clinical symptoms.
1 similar article
You are the first to view
Create an account
or login to join the discussion